nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alirocumab and cardiovascular outcomes according to sex and lipoprotein(a) after acute coronary syndrome: a report from the ODYSSEY OUTCOMES study
|
Bittner, Vera A. |
|
|
18 |
4 |
p. e548-e561 |
artikel |
2 |
Application of implementation science for improving the utilization of an international clinical practice guidance on familial hypercholesterolemia
|
Jones, Laney K. |
|
|
18 |
4 |
p. e525-e536 |
artikel |
3 |
Cascade screening for familial hypercholesterolemia from pediatric index cases diagnosed through universal screening
|
Lentz, Morgan |
|
|
18 |
4 |
p. e620-e624 |
artikel |
4 |
Detecting familial hypercholesterolemia: An observational study leveraging mandatory universal pediatric total cholesterol screening in Slovakia
|
Raslova, Katarina |
|
|
18 |
4 |
p. e537-e547 |
artikel |
5 |
Disparities in access to pharmacotherapies for weight loss and cardiovascular prevention
|
Duell, P. Barton |
|
|
18 |
4 |
p. e485-e487 |
artikel |
6 |
Effect of statin use on liver enzymes and lipid profile in patients with non-alcoholic fatty liver disease (NAFLD)
|
Ho, Anh |
|
|
18 |
4 |
p. e501-e508 |
artikel |
7 |
High carrier frequency for abetalipoproteinemia and evidence of a founder variant in a French-Canadian population
|
Guay, Simon-Pierre |
|
|
18 |
4 |
p. e625-e630 |
artikel |
8 |
Lipid-lowering optimisation for secondary prevention vascular and diabetic foot patients in a pharmacist-led clinic
|
Hart, Matthew |
|
|
18 |
4 |
p. e572-e578 |
artikel |
9 |
Longitudinal analysis of clinical and laboratory biomarkers in a patient with familial lecithin: cholesterol acyltransferase deficiency (FLD) and accelerated eGFR decline: A case study
|
Alfaro, Gregory |
|
|
18 |
4 |
p. e636-e643 |
artikel |
10 |
Long-term cardiovascular outcomes in a population-based multicentric cohort of northern Portugal: Validation of the ESC/EAS prognostic risk classification
|
Gavina, Cristina |
|
|
18 |
4 |
p. e562-e571 |
artikel |
11 |
Overcoming barriers to implementation: Improving incidental coronary calcium reporting on non-EKG gated chest CT scans
|
Grant, Jelani K. |
|
|
18 |
4 |
p. e610-e619 |
artikel |
12 |
Polycystic ovary syndrome: A review of diagnosis and management, with special focus on atherosclerotic cardiovascular disease prevention
|
Myerson, Merle L. |
|
|
18 |
4 |
p. e488-e500 |
artikel |
13 |
Rare genetic cerebrotendinous xanthomatosis (CTX) cases without cholestanol elevation but with prominent cholesterol-rich tendon xanthomas
|
Alves, Renato Jorge |
|
|
18 |
4 |
p. e631-e635 |
artikel |
14 |
Remnant cholesterol is associated with the progression and regression of metabolic dysfunction-associated steatotic liver disease in Chinese adults
|
Guo, Wen |
|
|
18 |
4 |
p. e509-e517 |
artikel |
15 |
Sex, racial, ethnic, and geographical disparities in major adverse cardiovascular outcome of glucagon-like peptide-1 receptor agonists among patients with and without diabetes mellitus: A meta-analysis of placebo-controlled randomized controlled trials
|
Rivera, Frederick Berro |
|
|
18 |
4 |
p. e588-e601 |
artikel |
16 |
The role of genetically-influenced phospholipid transfer protein activity in lipoprotein metabolism and coronary artery disease
|
Ao, Linjun |
|
|
18 |
4 |
p. e579-e587 |
artikel |
17 |
The triglyceride-glucose index is superior to homeostasis model assessment of insulin resistance in predicting metabolic syndrome in an adult population in the United States
|
Adams-Huet, Beverley |
|
|
18 |
4 |
p. e518-e524 |
artikel |
18 |
Unfavorably altered lipid profile in women with primary ovarian insufficiency
|
Magdalena, PirĂ³g |
|
|
18 |
4 |
p. e602-e609 |
artikel |